Electrochemical detection of agomelatine using a high-performance FeZn LDH/graphene/polyaniline nanocomposite sensor for clinical and pharmaceutical analysis
Microchimica Acta · 2025
DOI: 10.1007/s00604-025-07461-x ↗Kurz gefasst
Fachartikel in der Zeitschrift Microchimica Acta, 2025. Verfasst von Mohammad Omaish Ansari. Beteiligte Einrichtung: Center of Nanotechnology, King Abdulaziz University, Jeddah, 21589, Saudi Arabia. omaishchem@gmail.com. Hauptthemen laut MEDLINE: Nanocomposites, Graphite, Acetamides, Aniline Compounds. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: King Abdulaziz University.
Abstract (Originalsprache)
Therapeutic monitoring of agomelatine (AG), an antidepressant with significant pharmacokinetic variability, is hindered by the complexity and cost of conventional methods. This work presents a novel electrochemical sensor employing a ternary FeZn-layered double hydroxide (LDH)/graphene/polyaniline nanocomposite for sensitive AG detection in biological and pharmaceutical samples. The synergistic properties of the nanocomposite-combining catalytic activity, high conductivity, and electrochemical stability-were confirmed through XRD, FESEM-EDS, and XPS characterization. Electrochemical analysis showed a 65% reduction in charge transfer resistance and a 21-fold increase in electroactive surface area (0.576 cm2) compared with unmodified electrodes. Using square-wave voltammetry, the sensor achieved a broad linear detection range (5-140 nM), high sensitivity (950.7 nA nM-1 cm-2), and a low detection limit. It demonstrated excellent reproducibility (< 2.5% RSD) and high recoveries (96.9-102.9%) in human urine and commercial tablets, surpassing existing nanocomposite sensors. The sensor maintained performance against 100-fold excesses of common interferents (e.g., glucose, ascorbic acid, Na+, Ca2+). By overcoming key limitations in plasma compatibility and sensitivity, this FeZn LDH/graphene/polyaniline sensor offers a robust, sustainable platform for real-time AG monitoring, directly applicable in clinical diagnostics and pharmaceutical quality control.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center of Nanotechnology, King Abdulaziz University, Jeddah, 21589, Saudi Arabia. omaishchem@gmail.com.
Förderung
- King Abdulaziz University
Zitieren
APA
Ansari, M. O. (2025). Electrochemical detection of agomelatine using a high-performance FeZn LDH/graphene/polyaniline nanocomposite sensor for clinical and pharmaceutical analysis. Microchimica Acta. https://doi.org/10.1007/s00604-025-07461-x
Vancouver
Ansari MO. Electrochemical detection of agomelatine using a high-performance FeZn LDH/graphene/polyaniline nanocomposite sensor for clinical and pharmaceutical analysis. Microchimica Acta. 2025. doi:10.1007/s00604-025-07461-x
BibTeX
@article{Ansari2025,
author = {Ansari, Mohammad Omaish},
title = {Electrochemical detection of agomelatine using a high-performance FeZn LDH/graphene/polyaniline nanocomposite sensor for clinical and pharmaceutical analysis},
journal = {Microchimica Acta},
year = {2025},
doi = {10.1007/s00604-025-07461-x}
}
EUVIMED